risperidone has been researched along with Bright Disease in 1 studies
Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.
Bright Disease: A historical classification which is no longer used. It described acute glomerulonephritis, acute nephritic syndrome, or acute nephritis. Named for Richard Bright.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A patient with chronic renal failure (CRF) developed neuroleptic malignant syndrome (NMS) after administration of risperidone and levomepromazine." | 3.71 | Neuroleptic malignant syndrome complicated by massive intestinal bleeding in a patient with chronic renal failure. ( Fukasawa, T; Hayashi, H; Kawakatsu, S; Otani, K; Watanabe, K, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hayashi, H | 1 |
| Kawakatsu, S | 1 |
| Watanabe, K | 1 |
| Fukasawa, T | 1 |
| Otani, K | 1 |
1 other study available for risperidone and Bright Disease
| Article | Year |
|---|---|
Neuroleptic malignant syndrome complicated by massive intestinal bleeding in a patient with chronic renal failure.
Topics: Adult; Antipsychotic Agents; Gastrointestinal Hemorrhage; Glomerulonephritis; Humans; Kidney Failure | 2002 |